Focus on Transcatheter Aortic Valve ReplacementValidation of Administrative Claims to Ascertain Outcomes in Pivotal Trials of Transcatheter Aortic Valve Replacement
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
This study was funded by grant 1R01HL136708 from the National Heart, Lung, and Blood Institute (Dr. Yeh). Dr. Butala is funded by the John S. LaDue Memorial Fellowship at Harvard Medical School; and has received consulting fees from and has ownership interest in HiLabs, outside the submitted work. Dr. Strom is funded by grant 1K23HL144907 from the National Heart, Lung, and Blood Institute. Dr. Brennan holds an Innovation in Regulatory Science Award from the Burroughs Welcome Fund (1014158); holds grant 1U01FD004591-01 from the U.S. Food and Drug Administration; and is a consultant for Edwards Lifesciences and Atricure. Dr. Popma has received grants from Medtronic, Abbott Vascular, Cook, and Boston Scientific; and has received personal fees from Boston Scientific. Dr. Yeh has received additional grant support from Abiomed, AstraZeneca, and Boston Scientific; and has received consulting fees from Abbott, Boston Scientific, Medtronic, and Teleflex, outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Interventions author instructions page.